Akums Drugs and Pharmaceuticals Ltd has announced a temporary disruption of operations at certain manufacturing facilities located in the SIDCUL industrial area, Haridwar. The disruption, which occurred on May 14, 2026, is attributed to ongoing labour unrest. The company is actively engaging with workers and local authorities to resolve the situation and normalize manufacturing activities as quickly as possible.
Manufacturing Disruption Overview
On May 14, 2026, Akums Drugs and Pharmaceuticals Ltd experienced a temporary halt in operations at specific manufacturing units within its Haridwar cluster. The suspension of work follows labour unrest reported at the SIDCUL industrial area, a major hub for the company’s production activities.
Management Response and Mitigation
The company has confirmed that it is taking active measures to normalize operations at the affected sites. Currently, the management team is in direct discussions with the workforce and relevant local authorities to address the concerns of the employees. The primary objective is to reach an amicable resolution that allows for the swift resumption of production capabilities.
Future Outlook
Akums Drugs and Pharmaceuticals Ltd has committed to providing further updates as the situation develops. A full assessment regarding the impact of this disruption on overall output and schedules will be shared with stakeholders in due course as clarity emerges from the ongoing negotiations.
Source: BSE
